Search

Your search keyword '"Motohiro Fujiwara"' showing total 63 results

Search Constraints

Start Over You searched for: Author "Motohiro Fujiwara" Remove constraint Author: "Motohiro Fujiwara"
63 results on '"Motohiro Fujiwara"'

Search Results

1. Durable response to nivolumab rechallenge in a patient with metastatic clear cell renal cell carcinoma

2. Severe drug eruption after antibiotic administration in patients receiving immune checkpoint inhibitors: A monocentric case series

Catalog

Books, media, physical & digital resources

3. De novo large‐cell neuroendocrine carcinoma of the prostate: A case report and literature review

4. The utility of diffusion‐weighted whole‐body imaging with background body signal suppression in detecting metastatic lesion of germ cell carcinoma

5. Computer-aided diagnosis with a convolutional neural network algorithm for automated detection of urinary tract stones on plain X-ray

6. Virtual spherical-shaped multicellular platform for simulating the morphogenetic processes of spider-like body axis formation

7. Testicular seminoma with a progressing pulmonary nodule and mediastinal lymphadenopathy without retroperitoneal metastasis

8. Unusual metastasis from renal cell cancer after partial nephrectomy and sequential targeted therapy

9. Effectiveness and safety profile of pembrolizumab for metastatic urothelial cancer: A retrospective single‐center analysis in Japan

10. Pembrolizumab for a patient with metastatic castration‐resistant prostate cancer with microsatellite instability‐high

11. Case Report: A Case of Trimethoprim/Sulfamethoxazole-Triggered Hypotensive Shock: Cytokine Release Syndrome Related to Immune Checkpoint Inhibitors and Drug-Induced Hypersensitivity Syndrome

12. Neoadjuvant Chemoradiotherapy Followed by Radical Cystectomy for Muscle-Invasive Bladder Cancer: Analysis of Efficacy and Safety in 119 Patients.

14. Geriatric Nutritional Risk Index as a Predictor of Prognosis in Metastatic Renal Cell Carcinoma Treated with Nivolumab

15. Patterns of recurrence in genuine and induced oligometastatic castration‐resistant prostate cancer treated with progressive site‐directed therapy

19. PD36-07 DEFINING OPTIMAL CANDIDATES FOR BLADDER-SPARING TREATMENT IN MUSCLE-INVASIVE BLADDER CANCER: ANALYSIS USING PATHOLOGICAL REFERENCE STANDARDS AFTER CHEMORADIATION

20. Improving Accuracy, Reliability, and Efficiency of the RENAL Nephrometry Score With 3D Reconstructed Virtual Imaging

21. Early Serum and Hematological Responses to Pembrolizumab Therapy as Predictors of Survival in Metastatic Urothelial Cancer

22. Clinical Outcome and Prognostic Variables of Second-line Therapy for Patients With Castration-resistant Prostate Cancer After Failure of First-line Androgen Receptor Axis-targeted Therapy

23. Predictive ability of prebiopsy magnetic resonance imaging and biopsy for side‐specific negative lymph node metastasis at radical prostatectomy

25. Renal function outcome after selective bladder-preserving tetramodality therapy consisting of maximal transurethral resection, induction chemoradiotherapy and consolidative partial cystectomy in comparison with radical cystectomy for patients with muscle-invasive bladder cancer: a two-centre retrospective study

26. Significance of dorsal bladder neck involvement in predicting the progression of non-muscle-invasive bladder cancer

27. Serum and hematologic responses after three cycles of cabazitaxel therapy as predictors of survival in castration-resistant prostate cancer

28. The utility of diffusion‐weighted whole‐body imaging with background body signal suppression in detecting metastatic lesion of germ cell carcinoma

29. Diagnostic Value of the Vesical Imaging-Reporting and Data System in Bladder Urothelial Carcinoma with Variant Histology

31. Preservation of Erectile and Ejaculatory Functions After Tetramodal Bladder-Sparing Therapy Incorporating Consolidative Partial Cystectomy Against Muscle Invasive Bladder Cancer.

32. Efficacy, Prognostic Factors, and Safety Profile of Enzalutamide for Non-metastatic and Metastatic Castration-Resistant Prostate Cancer: A Retrospective Single-Center Analysis in Japan

33. Testicular seminoma with a progressing pulmonary nodule and mediastinal lymphadenopathy without retroperitoneal metastasis

34. Intraoperative Only versus Extended Duration Use of Antimicrobial Prophylaxis for Infectious Complications in Radical Cystectomy with Intestinal Urinary Diversion

35. Renal function outcomes in the early and intermediate phases after radical cystectomy by ileal conduit

36. Unusual metastasis from renal cell cancer after partial nephrectomy and sequential targeted therapy

37. MP15-17 PREDICTION MODEL FOR SIDE-SPECIFIC LYMPH NODE INVASION IN RADICAL PROSTATECTOMY AMONG PATIENTS WITH PROSTATE CANCER: FEASIBILITY OF SIDE-SPECIFIC LYMPH NODE DISSECTION

38. Effectiveness and safety profile of pembrolizumab for metastatic urothelial cancer: A retrospective single‐center analysis in Japan

39. Case Report: A Case of Trimethoprim/Sulfamethoxazole-Triggered Hypotensive Shock: Cytokine Release Syndrome Related to Immune Checkpoint Inhibitors and Drug-Induced Hypersensitivity Syndrome

40. External validation of the Briganti 2019 nomogram to identify candidates for extended pelvic lymph node dissection among patients with high-risk clinically localized prostate cancer

41. Switching Patients With Prostate Cancer from GnRH Antagonist to Long-acting LHRH Agonist for Androgen Deprivation: Reducing Hospital Visits During the Coronavirus Pandemic

42. Tissue growth constrains root organ outlines into an isometrically scalable shape

43. First-line combination chemotherapy with etoposide, ifosfamide and cisplatin for the treatment of disseminated germ cell cancer: Efficacy and feasibility in current clinical practice

44. Computer-aided Diagnosis with a Convolutional Neural Network Algorithm for Automated Detection of Urinary Tract Stones on Plain X-ray

45. Modified Glasgow Prognostic Score as a Predictor of Prognosis in Metastatic Renal Cell Carcinoma Treated With Nivolumab

46. MP62-12 PREDICTIVE ABILITY OF PREBIOPSY MULTIPARAMETRIC MAGNETIC RESONANCE IMAGING FOR NEGATIVE LYMPH NODE METASTASIS OF THE SIDE IN RADICAL PROSTATECTOMY: FEASIBILITY OF UNILATERAL LYMPH NODE DISSECTION

47. Cisplatin, Gemcitabine, and Paclitaxel as a Salvage Second-Line Therapy for Metastatic Germ-Cell Cancer

48. Preoperative inferior vena cava filter implantation to prevent pulmonary fat embolism in a patient showing renal angiomyolipoma extension into the renal vein: A case report and literature review

49. Renal function after bladder‐preserving therapy for patients with muscle‐invasive bladder cancer: Results of selective bladder‐preserving tetramodality therapy consisting of maximal transurethral resection, induction chemoradiotherapy and partial cystectomy

50. Modified Glasgow Prognostic Score as a Predictor of Prognosis in Metastatic Renal Cell Carcinoma Treated With Nivolumab.